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Research Highlights  
 Laccase degradation of non-phenolic  persistent TrOCs was investigated by EMR 
 TrOC loading greatly affected  enzymatic degradation of the resistant TrOCs 
 Redox-mediator notably improved TrOC degradation but increased effluent toxicity  
 Simultaneous addition of a redox-mediator and GAC enhanced enzymatic degradation  
 GAC addition to EMR reduced membrane fouling and toxicity of treated effluent 
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Abstract  
The removal of four recalcitrant trace organic contaminants (TrOCs), namely carbamazepine, 
diclofenac, sulfamethoxazole and atrazine by laccase in an enzymatic membrane reactor 
(EMR) was studied. Laccases are not effective for degrading non-phenolic compounds; 
nevertheless, 22–55 % removal of these four TrOCs in the range of was achieved by the 
laccase EMR. Addition of the redox-mediator syringaldehyde (SA) to the EMR resulted in a 
notable dose-dependent improvement (15-45%) of TrOC removal affected by inherent TrOC 
properties and loading rates. However, SA addition resulted in a concomitant increase in the 
toxicity of the treated effluent. A further 14-25% improvement in aqueous phase removal of 
the TrOCs was consistently observed following a one-off dosing of 3 g/L granular activated 
carbon (GAC).  Mass balance analysis reveals that this improvement was not due solely to 
adsorption but also enhanced biodegradation. GAC addition also reduced membrane fouling 
and the SA-induced toxicity of the effluent.  
Keywords: Enzymatic membrane reactor (EMR); granular activated carbon (GAC); laccase; 
redox-mediator; syringaldehyde; trace organic contaminants (TrOCs).  
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1. Introduction 
Enzymatic transformation of organic contaminants that are otherwise resistant to 
conventional activated sludge treatment is a promising eco-friendly concept (Jochems et al., 
2011). Enzymatic treatment can be accomplished under mild conditions, achieves high 
reaction specificity and rates, and generally only requires a small dosage. However, the 
application of enzymatic treatment in a continuous system remains a challenge due to enzyme 
washout with the treated effluent (Hai et al., 2012). The use of membranes with pore size 
smaller than the enzyme molecule presents an elegant approach to preventing enzyme wash 
out (Lloret et al., 2012). In an enzymatic membrane reactor (EMR), the enzyme remains 
within the reactor allowing operation with continuous feeding and treated effluent 
withdrawal. Compared to the conventional approach of enzyme immobilization on a suitable 
support material (Cabana et al., 2009), the EMR system offers several advantages such as 
more effective retention of enzymes, dispersion of enzymes in the reactor (eliminating the 
mass transfer limitations  typically associated with attachment on supports), and easy 
replenishment of fresh enzymes during long term operation.  
Recent studies have explored EMRs for the treatment of pollutants such as dyes and aromatic 
hydrocarbons (Chhabra et al., 2009; Mendoza et al., 2011). Trace organic contaminants 
(TrOCs) is a group of emerging pollutants that have been routinely detected in sewage and 
sewage-impacted natural water at concentrations ranging from ng/L to µg/L (Boonyaroj et 
al., 2012; Navaratna et al., 2012). TrOCs can be classified into several groups including 
pharmaceuticals and personal care products, pesticides, steroid hormones, phytoestrogens, 
and industrial chemicals. Many of these TrOCs can cause adverse physiological changes in 
aquatic organisms and can potentially affect human health after prolonged exposure. To date, 
the enzymatic removal of TrOCs has been mostly investigated in batch tests (Tran et al., 
2010; Yang et al., 2013a) using different enzymes such as laccase, lignin peroxidase, and 
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manganese peroxidase. Among these enzymes, laccase (Benzenediol: oxygen oxidoreductase; 
EC 1.10.3.2) is of particular interest as it only requires molecular oxygen as a co-substrate. 
Recent studies have demonstrated that laccase can effectively degrade a range of TrOCs that 
are otherwise resistant to conventional biological processes (Marco-Urrea et al., 2009; Tran et 
al., 2010; Yang et al., 2013a). TrOC removal by an enzymatic system is dependent on various 
factors including the molecular structure of the TrOCs, pH, temperature, and properties of the 
specific enzyme. To date, only one study has investigated continuous TrOC degradation by 
EMR (Lloret et al., 2012). Effective removal of two phenolic compounds (which are known 
as good substrates for laccase), namely estrone and 17β-estradiol, was demonstrated albeit 
over a limited observation period of 8 h. 
Phenolic substrates are particularly amenable to degradation by laccase. The substrate range 
of laccase can be expanded in the presence of small molecular weight redox-mediators that 
act as an ‘electron shuttle’ between the enzyme and the target compounds. The degree of 
enhancement depends predominantly on the type of mediator and TrOC structure (Yang et 
al., 2013a). However, TrOC degradation by the mediator-enhanced laccase system has been 
studied almost exclusively in batch tests. There is only one study utilising the addition of both 
laccase and hydroxybenzotriazole (HBT) every 8 h and achieving a carbamazepine removal 
of 60% within 24 h, compared to about 20% removal with a single addition of laccase and 
HBT (Hata et al., 2010). In this context, continuous dosing of a mediator to EMR may 
achieve an enhanced removal of TrOCs. However, no work in this line could be identified in 
the literature.  
Adsorption onto powdered activated carbon (PAC) or granular activated carbon (GAC) can 
efficiently remove TrOCs from water. However, limited adsorption of ionic compounds, 
particularly of those containing electron-withdrawing functional groups, has been reported. In 
this connection, the concept of combined processes such as coupling of membrane 
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bioreactors with PAC/GAC has been explored in a few recent studies (Li et al., 2011; Nguyen 
et al., 2013a). Available data confirms short-term enhancement in removal of resistant TrOCs 
but highlights the requirement of periodic withdrawal and replenishment of activated carbon. 
Because laccase can degrade TrOCs that are inefficiently degraded by conventional 
biological processes, activated carbon dosing to an EMR may lead to enhanced 
biodegradation rather than only temporary improvement in aqueous phase removal. However, 
no previous attempts have been made to validate this hypothesis. 
This study aims to investigate the removal of four selected TrOCs, known to be resistant to 
conventional activated sludge treatment, by an EMR using laccase. The two hypotheses noted 
above to enhance the degradation of TrOCs, namely (i) continuous addition of a redox-
mediator, and (ii) simultaneous addition of a redox mediator and GAC, have been 
systematically validated. Implications of GAC addition on TrOC removal, membrane fouling 
and the toxicity of the treated effluent are also discussed. 
2. Materials and methods 
2.1 Trace organic contaminants 
Three pharmaceutically active compounds, namely carbamazepine (CBZ), diclofenac (DCF), 
and sulfamethoxazole (SMX) and the pesticide atrazine (ATZ) were selected based on their 
widespread occurrence in raw sewage and sewage-impacted water bodies as well as their 
resistance to conventional biological treatment processes. These are non-phenolic compounds 
with molecular weights ranging from 215 (ATZ) to 296 (DCF) Da and with logD(pH=6) 
(indicating hydrophobicity) ranging from 0.43 (SMX) to 2.72 (DCF) (Supplementary Data 
Table S1). Analytical grade (> 98%) standards of these TrOCs were purchased from Sigma-
Aldrich (Castle Hill, NSW, Australia). A stock solution containing 1 g/L of each compound 
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was prepared in pure methanol. This stock solution was stored at −18 °C in the dark and was 
used within one month. 
2.2 Enzyme solution, mediator and granular activated carbon 
A commercially available laccase (Novozym 51003) purified from genetically modified 
Aspergillus oryzae was supplied by Novozymes Australia Pty Ltd. This enzyme has a 
molecular weight of 56 kDa. The enzyme stock solution had a density, purity and activity of 
1.12 g/mL, approximately 10% (w/w) and 150,000 µM/min (measured using 2,6-dimethoxy 
phenol (DMP) as substrate), respectively. 
The radicals generated due to oxidation of syringaldehyde (SA) by laccase have been 
reported to be more stable than those of other common redox-mediators (e.g. HBT) 
(González Arzola et al., 2009). Therefore, SA obtained from Sigma-Aldrich (NSW, 
Australia) was used in this study as the redox- mediator. A stock solution of SA was prepared 
in Milli-Q water at a concentration of 50 mM and stored at 4 °C.  
GAC-1200 (Activated Carbon Technologies Pty Ltd, Victoria, Australia) was chosen as 
adsorbent because of its high TrOC adsorption capacity (Nguyen et al., 2013a). The 
physicochemical characteristics of this GAC are summarized in Supplementary Data Table 
S2. Prior to the experiment, the GAC was washed with Milli-Q water to remove fine 
particles, dried at 105 °C for 24 h and stored at room temperature until use.  
2.3 Batch test description 
The impact of GAC and/or SA addition on enzymatic degradation of TrOCs was first 
investigated in batch tests. Parallel tests on different combinations (i.e., enzyme only, GAC 
only, enzyme + GAC, enzyme + SA, and enzyme + GAC + SA) were conducted with 200 
mL test media in 400 mL beakers. In all tests, each TrOC was added at an initial nominal 
concentration of 5000 µg/L (actual concentrations of 5600 ± 110, 4900 ± 160, 4700 ± 100, 
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and 4300 ± 400 µg/L for CBZ, DCF, SMX and ATZ, respectively). The initial enzymatic 
activity of the test solution was 90 µM/min. The enzymatic activity was selected based on a 
preliminary experiment (data not shown) showing that the enzymatic activity in the range of 
60 to 90 µM/min resulted in approximately 80% removal of DCF at an initial concentration 
of 1000 µg/L.  The enzymatic assay has been described in Section 2.5.2.  SA was added at a 
concentration of 10 µM and a GAC dosage of 20 mg/L was used. The initial concentrations 
of the TrOCs and GAC were selected such that the TrOC loading exceeded the maximum 
adsorption capacity of the GAC ( 250 and 94.3 mg/g GAC  for CBZ and DCF, respectively 
(Nguyen et al., 2013a)) allowing the effect of enzyme and mediators to  be clearly observed. 
Triplicate samples were collected after 24 h of incubation to measure TrOC removal from the 
aqueous phase. The samples were diluted two-fold in methanol to immediately stop any 
residual enzyme activity. TrOC adsorbed on GAC was measured by a solvent extraction 
method (Wijekoon et al., 2013). Freeze-dried GAC was thoroughly mixed with 5 mL of 
methanol. The mixture was then sonicated for 10 min and the supernatant was collected. The 
remaining solid mass was subjected to further extraction using 5 mL methanol and 
dichloromethane (1:1 v/v) and the supernatant was collected. The extracted TrOC in the 
solution was measured by HPLC analysis as described in Section 2.5.1. The extraction 
efficiency of CBZ, DCF, SMX and ATZ from GAC was 64, 98, 82 and 79%, respectively.  
2.4  Enzymatic membrane reactor system and operation protocol 
A laboratory scale EMR system consisting of a 1.5 L (active volume) glass reactor was used 
(Supplementary Data Figure S3). An ultrafiltration hollow fibre membrane made of 
polyacrylonitrile (Pall Corporation, NSW, Australia) was submerged in the reactor. The 
membrane had a nominal molecular weight cut off (MWCO), surface area and clean water 
flux of 6 kDa, 0.19 m2, and 10 L/h.bar, respectively.  
2.4.1 Confirmation of enzyme retention by the membrane 
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Stock solution (1 mL) of laccase was diluted to a final volume of 1.5 L in the reactor by 
Milli-Q water to obtain an initial enzymatic activity of approximately 90 µM/min. The 
membrane was operated at a flux of 1.1 L/m2.h via a peristaltic pump (Masterflex L/S, USA) 
for 24 h at 8 min on and 1 min off cycles, and the permeate was returned to the reactor. 
Enzymatic activity in permeate and reactor supernatant samples was measured every 30 min 
in the first 4 h, and then every 5 h until 24 h. The reactor was placed in a water bath with a 
temperature control unit (Julabo, Germany) to maintain the temperature at 28 °C. Dissolved 
oxygen (DO) concentration was maintained at above 3 mg/L via an air pump (ACO-002, 
Zhejiang Sensen Industry Co. Ltd, Zhejiang, China) connected to a diffuser placed at the 
bottom of the reactor. The pH of the reactor was 6.8 ± 0.2. Transmembrane pressure (TMP) 
was continuously monitored using a high-resolution (± 0.1 kPa) pressure sensor (SPER 
scientific 840064, Extech Equipment Pty Ltd, Victoria, Australia) connected to a computer 
for data logging.  
2.4.2  Stability of enzymatic activity  
In order to check the stability of enzymatic activity under the applied hydraulic conditions 
and continuous TrOC dosing (1660 µg/L.d), the EMR was operated at a hydraulic retention 
time (HRT) of 8 h with continuous permeate withdrawal. All other conditions were as 
described in Section 2.4.1. Operation was initiated with an enzymatic activity of 90 µM/min. 
Permeate samples from the membrane and supernatant samples from the reactor were taken 
every 5 h for determining TrOC removal and enzymatic activity until no enzymatic activity 
was detected in the reactor (72 h). Then, another dose of enzyme was added to the EMR to 
reinstate the enzymatic activity to the initial level (90 µM/min), and the above run was 
repeated.  
2.4.3 Continuous operation of the EMR 
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The EMR was continuously operated for 66 d to investigate TrOC degradation by laccase 
alone or laccase in the presence of GAC and/or SA. Based on the observed enzymatic 
stability (Section 2.4.2), laccase was injected (200 μL laccase/ L reactor volume) every 12 h 
to the EMR to maintain the enzymatic activity within a range of 70 to 100 µM/min. The 
whole experimental sequence has been detailed in Supplementary Data Table S4. Under each 
operation regime, the EMR was run for at least a period of 6 × HRT up to 45 × HRT, and 
samples for measuring TrOC concentration were collected at 2 × HRT following the 
operation condition change.    
The effect of SA addition at different concentrations (i.e., 5, 10 and 20 µM) was investigated 
under two nominal TrOC loadings (1600 and 830 µg/L.d). Mediator concentrations were 
selected based on the concentration range used in previous EMR studies targeting recalcitrant 
compounds such as dyes (Chhabra et al., 2009; Mendoza et al., 2011) . A single dose of GAC 
was added to the EMR on Day 30 to obtain a final GAC concentration of 3 g/L. The effect of 
GAC addition was assessed for 35 d.  
2.4.4 Membrane cleaning protocol 
The UF membrane was cleaned by in-situ Milli-Q water backwash at a flux of 24 L/m2.h (5 
seconds) when the TMP exceeded 40 kPa during any particular run. Additionally, the 
membrane was cleaned by ex-situ backwash with 1 L of Milli-Q water followed by 1 L of 
NaOCl (500 mg/L active chlorine) under a flux of 5 L/m2.h at the end of each run. To 
monitor the formation of an enzyme gel layer on the membrane surface, the enzymatic 
activity of the cleaning solution was measured after each ex-situ Milli-Q water backwash.   
2.5   Analytical methods 
2.5.1 TrOC analysis 
A HPLC system (Shimadzu, Kyoto, Japan), equipped with a 300 × 4.6 mm (5 µm pore size) 
C-18 column (Supelco Drug Discovery, Sigma-Aldrich, Australia) and an UV-vis detector, 
9 
 
was used to measure TrOC concentrations. The detection wavelength, column temperature, 
and sample injection volume were 280 nm, 20 °C, and 50 µL, respectively. The mobile phase 
comprised of acetonitrile and Milli-Q water buffered with 25 mM KH2PO4. Two eluents, A 
(80% acetonitrile and 20% buffer, v/v) and B (20% acetonitrile and 80% buffer, v/v) were 
delivered at 0.7 mL/min through the column for 30 min in a time-dependent gradient 
proportions [Time (min), B (%)]: [0, 85], [5, 40], [8, 0], [22, 85] (Hai et al., 2011). The limit 
of quantification for the analytes under investigation using these conditions was 
approximately 10 µg/L. The removal efficiency was calculated as 








Inf
Eff
C
C
R 1100 , where 
CInf and CEff are influent and effluent (permeate) concentrations of the TrOC, respectively.  
2.5.2 Enzymatic and toxicity assay 
Laccase activity was determined by monitoring the oxidation of 10 mM DMP in 100 mM 
sodium citrate buffer solution (pH 4.5) over 2 min at room temperature. The measurement 
was based on the change in colour and measured at λ = 468 nm by a spectrophotometer (UV-
Visible UV-1700, Shimadzu, Kyoto, Japan). Laccase activity was calculated from the molar 
extinction coefficient ε = 49.6/mM.cm and expressed in µM/min (Hai et al., 2012).  
The bacterial toxicity of feed and permeate was analysed in duplicate by measuring 
bioluminescence inhibition in Photobacterium leiognathi (ToxScreen3 assay; CheckLight 
Ltd, Israel) as described previously (Nguyen et al., 2013b). Toxicity was expressed as relative 
Toxic Unit (rTU), calculated as rTU=1/IC20, with IC20 (concentration of the sample required 
to kill 20% of the bacteria) determined by linear regression of the toxicity response vs. 
relative sample enrichment within the linear range of the concentration-effect curve (up to 
IC40). 
3. Results and discussion 
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3.1 Batch tests: assessment of treatment capacity of each option studied 
Although phenols are typical laccase substrates, laccase can directly oxidize some non-
phenolic compounds if the electrochemical potential of the laccase used is sufficiently high 
(González Arzola et al., 2009). However, the laccase preparation used in this study did not 
efficiently degrade the tested non-phenolics (Table 1), with the highest removal of 21% being 
achieved for DCF. Similarly, even after SA addition, except for DCF (64%) all compound 
removals ranged between 16 and 31%. The recalcitrance of the selected TrOCs in this study 
can be attributed to their chemical structures. According to Tadkaew et al. (2011) the 
presence of electron withdrawing groups (EWG) in TrOCs imparts resistance to oxidative 
catabolism. Therefore the low removal of CBZ can be attributed to the presence of strong 
EWG amide in its structure (Yang et al., 2013a). The low removal of the chlorinated TrOCs 
DCF and ATZ can similarly be explained by the fact that chloride is a strong EWG. This is 
consistent with a report by Tran et al. (2010) who also observed the resistance of chlorinated 
TrOCs to laccase treatment. Resistance of ATZ is also consistent with previous reports on 
inherent resistance of triazine pesticides (Navaratna et al., 2012). Among the sulfonamide 
antibiotics, thus far, only limited information on the enzymatic degradation of SMX is 
available. Consistent with this study, Yang et al. (2013b)   reported negligible removal of 
SMX by a crude extracellular extract preparation (mainly laccase) from Trametes versicolor.  
[TABLE 1] 
Only DCF degradation was significantly improved by SA addition (Table 1). This may be 
due to the presence of the aromatic amine group (an electron donating group, EDG) in its 
structure, which possibly lowers its redox potential and makes it amenable to oxidation by 
laccase preparation when amended with SA. However, it could not be clarified why despite 
having an amine group, SMX removal efficiency improved by only 8% compared to 43% for 
DCF. This observation, however, is consistent with reports from other studies investigating 
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the electrochemical behavior of DCF (Blanco-Lopez et al., 2005) and SMX (Msagati & 
Ngila, 2002) at carbon electrodes: DCF appears to be electrochemically irreversibly oxidized 
at lower electric potential than SMX. It is also interesting to note that unlike in this study, 
Weng et al. (2012) observed significant improvement in the removal of sulfadimethoxine and 
sulfmanomethoxine, which have a similar backbone structure  to SMX. This may be 
explained by the fact that the oxidation reduction potential of the SA-amended laccase 
solution in this study (540 mV) was lower than that in the study (626 mV) by Weng et al. 
(2012). 
When only GAC was added to the test solution, 49-60% TrOC removal from the aqueous 
phase was achieved (Table 1). Therefore, it was not a surprise that the aqueous phase removal 
ranged from 64-76% with the simultaneous addition of laccase, SA and GAC. However, it is 
interesting to note that this improvement in aqueous phase removal (compared with that 
achieved by the laccase—SA system) was not only due to adsorption on GAC, but also due to 
enhanced enzymatic degradation. The fate of TrOCs (i.e., residual amount in liquid phase, 
adsorbed onto GAC and biodegraded) was assessed by extracting residual TrOC from the 
GAC at the end of the incubation period. The adsorbed amount onto GAC was calculated 
taking the extraction efficiency into account. It was revealed that a 12-45% increase in the 
extent of enzymatic degradation occurred in presence of GAC (Figure 1). Apparently co-
adsorption of enzyme and TrOC onto GAC facilitated enhanced TrOC degradation. Zille et 
al. (2003) observed that compared to dye adsorption on alumina, immobilization of enzyme 
on alumina led to a more consistent dye removal performance due to combined adsorption 
and biodegradation. Enhanced enzymatic degradation could be further advantageous in a 
continuous process wherein TrOCs are constantly loaded to the system.  
[FIGURE 1] 
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3.2 Performance of EMR 
3.2.1 Maintenance of enzymatic activity during EMR operation 
Given the molecular weight of the enzyme (56 kDa), it was expected to be retained by the 
membrane with a MWCO of 6 kDa used in this study. Indeed during continuous filtration 
over a period of 24 h (Section 2.4) no enzymatic activity in the permeate was observed, while 
that in the reactor supernatant remained stable (Supplementary Data Figure S5). Thus it was 
confirmed that the membrane effectively retained the enzyme. 
In addition to enzyme retention, the maintenance of enzyme activity during EMR operation is 
an important factor. Denaturation of enzyme due to various factors including physical, 
chemical and biological inhibitors and the effect of shear stress during filtration has been 
reported in the literature. The situation may be further exacerbated when a wastewater 
containing the target pollutant is continuously introduced to the reactor (Mendoza et al., 
2011). There is only one study on continuous TrOC (estrone and estradiol) degradation by an 
EMR (Lloret et al., 2012), where no enzyme denaturation within the short observation period 
of 8 h was observed. In this study, however, a gradual drop in the enzymatic activity within 
the reactor was noted beyond 24 h of continuous operation (data not shown), although the 
enzyme was still undetectable in the permeate, indicating that the observed decrease in 
enzymatic activity was due to enzyme denaturation rather than the permeation of enzyme 
through the membrane. To sustain continuous operation, a low dose laccase injection protocol 
was developed following several trials: the enzymatic activity was maintained at 70-100 
µM/min by addition of 200 µL of the commercial laccase solution per L of the reactor 
volume every 12 h (equivalent to a laccase dose of 23 mg/L.d).  
3.2.2 Continuous removal of TrOC by EMR 
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The removal efficiency of the compounds by the EMR followed the same order as in batch 
tests, i.e., DCF>ATZ>CBZ>SMX. Although a direct comparison of removal efficiency 
between two operation modes (i.e., batch vs. continuous) may not be valid, it is notable that 
the removal efficiency of DCF by the EMR was around 60% (Figure 2), which was three 
times that achieved during batch tests. The removal of the other compounds by EMR was 
slightly higher as well. The improved removal by the EMR despite continuous dosing of 
TrOCs can be attributed to the fact that in order to assess the contribution of adsorption and 
biodegradation, the batch tests (Section 2.3) were conducted under an initial TrOC 
concentration (5000 µg/L) 10 times that fed to the EMR. The effect of TrOC loading on the 
performance of the EMR was directly evidenced by a compound-specific improvement (3 to 
12%) in removal efficiency when the TrOC loading was reduced to approximately half from 
1660 µg/L.d (Figure 2 and Supplementary Data Table S6). The removal of these non-
phenolic TrOCs by EMR has not been reported before. However, the effect of TrOC loading 
was also demonstrated in a study by Lloret et al. (2012), who reported that the removal of 
estrone (a phenolic TrOC) increased from 64 to 73% when the loading decreased from 4 
mg/L.h to 1 mg/L.h.  
 [FIGURE 2] 
 
3.3 Impact of mediator addition on EMR performance 
In a laccase—mediator system, the role of laccase is to oxidize the mediator, while the actual 
oxidation of the substrate takes place in a subsequent non-enzymatic step by the action of the 
oxidized mediator species. The oxidation of SA by laccase generates highly active phenoxyl 
(C6H5O
*) radicals, which then target substrate via a hydrogen atom transfer (HAT) route 
(Fabbrini et al., 2002). This HAT mechanism has been implicated for the oxidation of 
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resistant species such as non-phenolic compounds. However, to date the use of mediators to 
improve TrOC removal has been reported in mostly batch test studies (Yang et al., 2013a).   
In this study the addition of SA to EMR resulted in significant improvement in TrOC 
removal depending on the mediator dose as well as the TrOC type and loading (Figure 2 and 
Supplementary Data Table S6). Two notable observations were made: (i) achievement of 
significant improvements in removal up to a mediator dose of 10 µM, and (ii) the impact of 
TrOC loading on the removal performance by the laccase—SA system.  
No continuous flow EMR study on TrOC removal could be found in the literature to compare 
our data to. There is one batch study which was conducted with repeated addition of laccase 
and a mediator (HBT) every 8 h for CBZ removal over a period of 48 h (Hata et al., 2010). 
Following this strategy, the authors reported an elimination of 60%, which compared 
favourably with a removal of 20% achieved via a single dose of HBT. In general, the better 
performance of the laccase—SA system may be explained by two factors attributable to the 
radical species generated from SA by laccase: i) higher redox potential, and ii) reduction of 
steric hindrance. Low molecular weight mediators can interact with complex compounds that 
cannot access the active sites of the enzyme directly. Moreover, compounds with high 
electrochemical potential can be oxidized by radical mediators (i.e., phenoxyl) through the 
operation of H-abstraction mechanism.  
Our results are in line with the general trend observed in the literature that pollutant removal 
profile may reach a plateau beyond a certain mediator concentration (10 µM in this study) 
(Mizuno et al., 2009). This occurs because the free radicals generated from laccase—
mediator systems that can improve pollutant degradation may also inactivate laccase by 
oxidizing the aromatic amino acid residues on the proteinaceous enzyme surface (Khlifi-
Slama et al., 2012). Another notable observation in this study was the impact of TrOC 
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loading on the performance of the laccase—SA system. During EMR operation, the effect of 
TrOC loading was particularly significant for ATZ (Figure 2). Furthermore, compared with 
batch tests, which were conducted under higher (10 times) TrOC concentrations (Table 1), 
better performance during EMR operation with the same SA dose (10 µM) was observed for 
all tested TrOCs except DCF, which was well removed in both cases. This observation once 
again illustrates the significant impact of TrOC loading on enzymatic removal of the resistant 
TrOCs. At high substrate concentrations, when almost all of the enzyme molecules are bound 
to the substrate, the reaction rate is dependent solely on the amount of enzyme and, therefore, 
occurs with zero-order kinetics.  
In this study, continuous dosing of the mediator was required because it was not retained by 
the membrane utilized. It is noted that continuous dosing of mediators to EMR may hinder its 
applicability due to mediator cost and complexity of operation. In this context, 
immobilization of the mediator or its recovery from the treated effluent may be applied. For 
example, Mendoza et al. (2011) confirmed that a membrane with  a MWCO of 10 kDa could 
retain the mediator TEMPO which was immobilized on polyethylene glycol. The EMR was 
operated up to nine batches to treat a dye wastewater with a single addition of the mediator. 
In another study by Chhabra et al. (2009), a recovery of 70% of ABTS was achieved from the 
treated effluent using ammonium sulphate precipitation method. It would be interesting to 
observe TrOC removal with the incorporation of such strategies. However, it is beyond the 
scope of the current study 
 
3.4 Effect of GAC addition on EMR performance 
Following the single dose addition of GAC, the EMR was operated for 35 d with continuous 
feeding and periodic injection of laccase. The TrOC loading and SA concentration were 
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varied systematically over 830 – 1660 µg/L.d and 5—20 µM, respectively (Supplementary 
Data Table S4). A stable and improved removal of all three resistant TrOCs (i.e., CBZ, SMX 
and ATZ) was observed for SA concentrations of 5 and 10 µM (Figure 3 and Supplementary 
Data Table S6). For example, with a SA dose of 5 µM and a TrOC loading of 830 µg/L.d 
(each), 14-25% improvement in removal was observed following GAC addition (Figure 3). 
Notably, irrespective of TrOC loading and SA dose, the removal of DCF remained around 
80%, which was already achieved without GAC addition. 
[FIGURE 3] 
Over the period of continuous operation of the EMR following GAC addition, the total mass 
of TrOCs fed to the reactor did not exceed the maximum adsorption capacity of the GAC 
added to the EMR.  However, data from EMR operation, in line with the batch test data, 
indicates that the improved and stable aqueous phase removal achieved by the GAC-amended 
EMR was not only due to adsorption of TrOCs but also due to subsequent enzymatic 
degradation of the adsorbed amount. At the end of the EMR operation, residual amounts of 
TrOCs on GAC were measured and a mass balance was conducted which revealed that a 
major portion of the TrOCs retained within the EMR (as indicated by the difference in TrOC 
concentration in feed and permeate) was biodegraded (Table 2). Removal of the selected 
TrOCs in this study by volatilization was expected to be negligible because of the very low 
vapour pressure or Henrys’s constant (H) and low H/log D ratio (Supplementary Data Table 
S1) of the TrOCs investigated, and photolysis was avoided by covering the EMR. Thus, 
enzymatic degradation appeared to be the major mechanism of TrOC removal by the GAC-
amended EMR system. 
[TABLE 2] 
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The results reported here indicate that in a GAC-amended EMR system, simultaneous 
adsorption of TrOCs and enzyme on GAC can enable enhanced enzymatic degradation of 
TrOCs bound on GAC, and lead to overall improvement of TrOC degradation, possibly 
because it promotes the interaction of TrOCs with the active sites of enzyme. Similar 
phenomena have been observed when activated carbon (GAC or PAC) was added to 
conventional membrane bioreactors (Li et al., 2011) or fungal reactors (Hai et al., 2008; 
Zhang & Yu, 2000). For example, Zhang and Yu (2000) encapsulated PAC inside fungal 
mycelium pellets and applied them for the removal of dye. It was shown that the PAC 
facilitated co-adsorption of the dye molecules and the extracellular enzyme secreted by 
fungal cells and achieved enhanced dye degradation. Co-adsorption of enzyme and dye on 
PAC and subsequent enzymatic dye degradation was also confirmed in a study by Hai et al. 
(2008). Moreover, it is possible that the adsorption of enzyme on GAC stabilizes enzymatic 
activity. This is supported by the observations made in studies involving enzyme 
immobilization on activated carbon (Jochems et al., 2011). The adsorption of TrOCs on GAC 
can also enhance degradation by increasing the contact time between the TrOCs and the 
enzyme.  
3.5 Membrane performance 
3.5.1 Role of the membrane in TrOC removal 
A significant level of enzymatic activity in the membrane cleaning solution from ex-situ 
Milli-Q backwashing was observed in this study. The enzymatic activity in 1 L of the 
cleaning solution was 60 µM/min, which was equivalent to an accumulation of at least 0.24 g 
active laccase per m2 of membrane surface. This demonstrated that an enzyme gel layer was 
formed on the membrane surface. Therefore, the TrOC concentration in permeate and 
supernatant of the reactor was measured periodically to investigate if there was any additional 
removal by the membrane and/or enzyme layer on the membrane. The ratio of concentration 
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of TrOCs in permeate and supernatant (P/S ratio) was indeed below 1 for all TrOCs (Figure 
4). Without addition of SA or GAC, the lowest P/S ratio was observed in case of DCF 
(0.52±0.02, n=11). Interestingly, the P/S ratio of DCF did not change significantly following 
addition of SA or GAC, which is consistent with its high removal by laccase alone (Figure 2).  
Conversely, for a TrOC loading of 830 µg/L.d, the P/S ratios of CBZ and ATZ dropped 
significantly following GAC addition. It is noted that GAC particles did not significantly 
accumulate on the membrane surface, rather remained mainly in suspension by aeration 
within the reactor. However, the drop in P/S ratio indicates that adsorption on the suspended 
GAC facilitated retention of TrOCs within the reactor.  
No EMR study could be found to directly compare these results, but the observations made in 
this study are in line with that by Li et al. (2011) who reported significant additional removal 
of CBZ and SMX by a microfiltration membrane submerged in a conventional activated 
sludge bioreactor to which PAC was added. A stable TrOC removal was achieved throughout 
this study, and there was no accumulation of TrOCs within the EMR (as evidenced by a 
stable concentration in the reactor supernatant). It can therefore be said that TrOCs adsorbed 
on the enzyme gel layer over the membrane were subsequently degraded. Dosing of GAC to 
an EMR can realize advantages additional to improved TrOC degradation, and these aspects 
have been discussed in Sections 3.5.2 and 3.6. 
[FIGURE 4] 
 
3.5.2 Membrane fouling 
Membrane fouling is an important aspect that requires due consideration when operating a 
continuous flow EMR. The formation of an enzyme gel layer on the membrane (Section 
3.5.1) can lead to its gradual fouling (Jochems et al., 2011). In this study, during EMR 
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operation without GAC, a TMP build up rate of approximately 9 kPa/d was observed (Figure 
5). By contrast, following GAC addition, an initial TMP build up rate of approximately 3.3 
kPa/d was noted, which further dropped to 2.5 kPa/d within a month of operation after the 
single dose addition of GAC.  
 
The data reported here suggests that a dynamic layer of adsorbent over the membrane can be 
beneficial for long-term restoration of the membrane permeability. It is also likely that the 
scouring action of the GAC particles helped to restrict the overgrowth of the enzyme gel 
layer on the membrane surface, thus reducing the overall hydrodynamic boundary layer 
thickness on the membrane compared with operation without GAC. Previous studies have 
demonstrated that the addition of adsorbents such as activated carbon (PAC or GAC) can 
mitigate membrane fouling in membrane bioreactors (Ng et al., 2013). This study, however, 
is possibly the first to demonstrate the advantage of GAC dosing for mitigation of membrane 
fouling in an EMR.  
 [FIGURE 5] 
 
3.6 Toxicity of treated effluent 
A few recent batch test studies have shown increased toxicity of enzyme-treated media 
despite efficient degradation of the target pollutant (Marco-Urrea et al., 2009). In this study, a 
ToxScreen3 assay (Section 2.5.2) revealed no significant toxicity in the feed irrespective of 
the feed concentration (6.6 ± 0.3 rTU; n=4) indicating that the tested TrOCs were not 
particularly toxic to the indicator bacterium (P. leiognathi) used in this study (Supplementary 
Data Figure S7). There was also no appreciable increase in toxicity in the EMR permeate (7.0 
± 1.7 rTU; n=2), suggesting that treatment did not produce toxic by-products. On the other 
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hand, addition of the redox-mediator SA to the EMR considerably increased the toxicity of 
the permeate. The toxicity of treated effluent with SA dosage of 5 µM and 10 µM was 20.1 ± 
5 (n=2) and 41.7 ± 2.1 rTU (n=2), respectively. This corresponds to 2.8× and 6.0× increase in 
toxicity, respectively. 
The observed toxicity of treated effluent after  SA addition is consistent with a report by 
Fillat et al. (2010) who studied the treatment of flax pulp. The toxicity of the treated medium, 
despite efficient TrOC removal after SA addition, may be due to the phenoxyl radicals 
formed in the laccase—SA system and/or the metabolites produced during the TrOC 
degradation. However, the toxicity test for SA itself (incubation with SA solution in the 
absence of laccase) revealed no toxicity (data not shown). Therefore, the toxicity of the media 
after enzymatic treatment with or without SA and the negligible toxicity of SA itself indicates 
that the effluent toxicity is most likely due to the radicals formed in the presence of both 
laccase and SA. This observation is in accordance with that by Kim and Nicell (2006) who 
suggested that radicals formed due to oxidation of mediators can interact with vitally 
important biomolecules and result in cytotoxic effects. 
 
Nevertheless, bacterial assay can only provide a limited measure of ecotoxicity, and while the 
toxicity results clearly indicate that the effluents are toxic to bacteria, further tests using other 
organisms are needed to more thoroughly appreciate the potential ecological risks. Moreover, 
further work is required to screen mediators which enhance enzymatic degradation without 
raising the toxicity of the treated media. In this context, it is interesting to note that a 
significant reduction in effluent toxicity originating from SA dosing was observed after the 
addition of GAC to the EMR (Figure 6). In fact, following GAC addition, the treated effluent 
demonstrated no elevated toxicity with a SA dose of 5 µM. It has been previously reported 
that the effects of shock loads or toxic concentrations of pollutants/chemical species can be 
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buffered as a result of their adsorption onto activated carbon. For example, PAC addition to 
an MBR treating tannery wastewater was shown to reduce the negative effects of natural and 
synthetic tannins that impart toxicity (Munz et al., 2007). Systematic demonstration of the 
problem of effluent toxicity originating from mediator dosing to EMR and proposal of a 
solution is a unique contribution of the current study. 
 
4. Conclusion  
This is the first report on the multiple advantages of GAC dosing to an EMR: (i) 
enhancement of TrOC degradation by a laccase—mediator (syringaldehyde) system, (ii) 
reduction of mediator-induced effluent toxicity, and (iii) mitigation of fouling by an enzyme 
gel layer over the membrane. TrOCs adsorbed onto the enzyme layer, and GAC addition 
further facilitated such TrOC retention on the membrane cake layer; nevertheless, subsequent 
TrOC degradation was confirmed. At a TrOC loading, mediator concentration and GAC dose 
of 830 µg/L.d, 5 µM, and 3 g/L, respectively, removal efficiency ranged from 65% 
(sulfamethoxazole) to 80% (diclofenac). 
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Table 1: Aqueous phase TrOC removal efficiencies by different options in batch tests 
  
Compounds 
Aqueous phase removal (%)
Enzyme 
only 
Enzyme + 
SA 
GAC only 
Enzyme + 
GAC 
Enzyme + 
SA + 
GAC 
Carbamazepine 10 16 49 52 71 
Diclofenac 21 64 60 63 67 
Sulfamethoxazole 9 17 53 58 64 
Atrazine 14 31 57  75 76 
Standard deviation of 3 replicate experiments was less than 5%. Initial enzymatic activity was 
90 µM/min. Carbamazepine, diclofenac, sulfamethoxazole and atrazine concentrations of 
5600 ± 110, 4900 ± 160, 4700 ± 100, and 4300 ± 400 µg/L, respectively were applied. SA 
and GAC concentrations were 10 µM and 20 mg/L, respectively.  
 
Table 2: Fate of TrOCs retained within EMR 
 
Compounds 
Total mass of TrOC (mg)a 
Biodegradation 
(%)b In (I) Out (O) 
Residual on 
GAC (R) 
     
Carbamazepine 94 45 8 84 
Diclofenac 85 19 1 99 
Sulfamethoxazole 76 34 1 97 
Atrazine 76 35 7 82 
a  At the end of the 35 d operation period (with GAC addition) during which the EMR was operated 
under different TrOC loadings and SA concentrations as detailed in Supplementary Data Table S4. 
b Biodegradation of the amount retained within the reactor was calculated as 
100
)(
(%)deg 



OI
ROI
radationBio  
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LIST OF FIGURE 
Figure 1: Overall fate of TrOCs following treatment (24 h) via the tested options.  
Figure 2: TrOC removal efficiencies by the EMR during operation under different mediator 
concentrations (5, 10 and 20 µM) and TrOC concentrations (i.e., 0.5 and 0.25 mg/L 
corresponding to loadings of 1660 and 830 µg/L.d, respectively). 
Figure 3: Enhancement of enzymatic degradation due to addition of GAC (3 g/L) and/or 
mediator (5 µM) under different TrOC concentrations (i.e., 0.5 and 0.25 mg/L corresponding 
to loadings of 1660 and 830 µg/L.d, respectively). The error bars represent the standard 
deviation of available data points (n =11-34, depending on the option). 
Figure 4: Ratio of TrOC concentration in membrane permeate and reactor supernatant during 
different runs. The error bars represent the standard deviation of available data (n =11-34, 
depending on the option).   
Figure 5: Variation of transmembrane pressure (TMP) as a function of operating time 
showing the impact of GAC addition to EMR.  
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Table S1: Physicochemical properties of the selected TrOCs 
Compounds Molecular Log KOW
a Log Dissociation Vapour Chemical structure 
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(CAS number) weight 
(g/mol) 
D at 
pH 6a 
constant 
(pKa)a 
pressure 
(mg Hg) 
at 25 °Ca 
Carbamazepine 
(C15H12N2O) 
(298-46-4) 
236.27 1.89 ± 0.59 1.89 
13.94 ± 0.20 
-0.49 ± 0.20 
5.68 x 10-7 
 
Diclofenac 
(C14H11Cl2NO2) 
(15307-86-5) 
296.15 4.55 ± 0.57 2.72 
4.18 ± 0.10 
-2.26 ± 0.50 
 
1.59 x 10-7 
Sulfamethoxazole 
(C10H11N3O3S) 
(723-46-6) 
253.28 0.66 ± 0.41 0.43 
5.81 ± 0.50 
1.39 ± 1.10 
1.87 x 10-9 
 
Atrazine 
(C8H14ClN5) 
(1912-24-9) 
215.68 2.63±0.20 2.64 2.27±0.10 1.27 x 10-5 
 
a Source: SciFinder database: https://origin-scifinder.cas.org  
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Table S2:  Physicochemical characteristics of the GAC-1200 
Parameter Values 
Apparent density (g/mL) 0.42-0.50
a 
Surface area (MultiPoint BET m2/g) 1121
b  
Ash content (%) 3
a 
Iodine number (mg of I2/g) >1200
a 
Carbon mesh size 6 x 12 mesh (1.6-2.0 mm)
a  
Pore volume (cc/g) 0.043
b 
Pore diameter (nm) 3.132
b 
a Data from Activated Carbon Pty Ltd, Australia. 
b Data obtained from a nitrogen adsorption/desorption measurement using an Autosorb iQ. 
The measurement was conducted at the Australian Nuclear Science and Technology 
Organisation. Pore volume and pore diameter were calculated based on the Barret-Joyner-
Halenda method. 
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Table S4: Sequence of the experiments and the relevant operating conditions of the 
enzymatic membrane reactor 
Day Experiment 
TrOC loading rate 
(µg/L.day) 
Sampling 
interval 
(h) 
 
TrOC 
conc., 
(mg/L) 
SA 
(µM) 
GAC 
(g/L) 
Compounds  
CBZ DCF SMX ATZ  
0 – 4  0.5 - - 2060 ± 60 1860 ± 60 1700 ± 30 1660 ± 60 5 
5 – 8 0.5 5 - 
1830 ± 
160 
1730 ± 
130 
1660 ± 60 1660 ± 60 5 
9 – 13 0.5 10 - 2030 ± 60 1800 ± 60 1760 ±30 
1900 ± 
100 
5 
14 – 18 0.5 20 - 
2130 ± 
160 
1800 ± 30 1800 ± 60 
1860 ± 
130 
5 
19 – 23 0.25 - - 930 ± 30 900 ± 160 850 ± 30 880 ± 160 8 
24 – 26 0.25 5 - 930 ± 30 900 ± 50 860 ± 30 860 ± 30 4 
27 – 29 0.25 10 - 930 ± 50 860 ± 30 900 ± 50 860± 30 4 
30 – 46 0.5 5 3 
2230 ± 
160 
1800 ± 
100 
1700 ± 60 
1830 ± 
130 
11 
47 – 55 0.25 5 3 
1000 ± 
160 
100 ± 30 930 ± 60 760 ± 60 10 
56 – 61 0.25 10 3 1060 ± 60 960 ± 30 960 ± 60 830 ± 100 8 
62 – 66 0.25 20 3 1060 ± 50 1000 ±30 960  ± 30 900 ± 100 6 
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Figure S5: Confirmation of complete retention of the enzyme by the membrane  
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Table S6: Summary of the TrOC removal efficiencies by the treatment options studied 
    Removal efficiency (%)  
Compounds 
TrOC 
conc., 
(mg/L) 
TrOC 
loading 
(µg/L.d) 
Enzyme 
only 
Enzyme +  SA Enzyme + SA + GAC 
 
SA concentration (µM) 
   0 5 10 20 5 10 20 
CBZ 0.5 
1660 
25 ± 4 
(n = 20) 
23 ± 6 
(n =15) 
40 ± 4 
(n = 17) 
53 ± 24 
(n = 15) 
50 ± 9 
(n = 34) 
  
 0.25 
830 
28 ± 5 
(n = 11) 
41 ± 9 
(n =11) 
55 ± 6 
(n = 11) 
 
66 ± 8 
(n = 20) 
74 ± 4 
(n = 16) 
34 ± 7 
(n = 16) 
  
        
DCF 0.5 
1660 
55 ± 4 
(n = 20) 
75 ± 13 
(n =15) 
87 ± 4 
(n = 17) 
88 ± 5 
(n= 15) 
78 ± 14 
(n = 34) 
  
 0.25 
830 
64 ± 3 
(n = 11) 
76 ± 5 
(n =11) 
82 ± 2 
(n = 11) 
 
78 ± 5 
(n = 20) 
75 ± 2 
(n = 16) 
73 ± 6 
(n = 16) 
  
        
SMX 0.5 
1660 
13 ± 4 
(n = 20) 
34 ± 9 
(n =15) 
75 ± 5 
(n = 17) 
73 ± 9 
(n = 15) 
48 ± 8 
(n = 34) 
  
 0.25 
830 
25 ± 5 
(n = 11) 
51 ± 6 
(n =11) 
67 ± 4 
(n = 11) 
 
65 ± 6 
(n = 20) 
68 ± 3 
(n = 16) 
64 ± 4 
(n = 16) 
  
        
ATZ 0.5 
1660 
22 ± 6 
(n = 20) 
31 ± 5 
(n =15) 
37 ± 7 
(n =17) 
35 ± 6 
(n = 15) 
38 ± 8 
(n = 34) 
  
 0.25 
830 
34 ± 9 
(n = 11) 
61 ± 6 
(n =11) 
78  ± 8 
(n = 11) 
 
79 ± 7 
(n = 20) 
89 ± 6 
(n = 16) 
56 ± 13 
(n = 16) 
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Figure S7: Toxicity of EMR effluent depending on the mediator concentration and the impact 
of GAC addition. The error bars represent the standard deviation of two samples.  
 
